<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: FDA Allows High-Yield Tysabri Production</title>
	<atom:link href="http://www.xconomy.com/boston/2009/04/16/fda-allows-high-yield-tysabri-production/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/04/16/fda-allows-high-yield-tysabri-production/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Antibody Industry Week in Review &#124; 4.20.09 — The Antibody Blog</title>
		<link>http://www.xconomy.com/boston/2009/04/16/fda-allows-high-yield-tysabri-production/comment-page-1/#comment-54046</link>
		<dc:creator>Antibody Industry Week in Review &#124; 4.20.09 — The Antibody Blog</dc:creator>
		<pubDate>Mon, 20 Apr 2009 05:04:45 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=20499#comment-54046</guid>
		<description>[...] FDA approved Biogen Idec&#8217;s high yield Tysabri production [...]</description>
		<content:encoded><![CDATA[<p>[...] FDA approved Biogen Idec’s high yield Tysabri production [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

